Home - Products - Others - Other Targets - 3-Bromo-6-chloro-2-pyridinecarboxylic acid

3-Bromo-6-chloro-2-pyridinecarboxylic acid

CAS No. 929000-66-8

3-Bromo-6-chloro-2-pyridinecarboxylic acid( —— )

Catalog No. M37023 CAS No. 929000-66-8

3-Bromo-6-chloro-2-pyridinecarboxylic acid is a biochemical reagent that can be used to synthesize other compounds.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 37 In Stock
50MG 53 In Stock
100MG 77 In Stock
200MG Get Quote In Stock
500MG 193 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    3-Bromo-6-chloro-2-pyridinecarboxylic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    3-Bromo-6-chloro-2-pyridinecarboxylic acid is a biochemical reagent that can be used to synthesize other compounds.
  • Description
    3-Bromo-6-chloro-2-pyridinecarboxylic acid is a biochemical reagent that can be used to synthesize other compounds.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    929000-66-8
  • Formula Weight
    236.45
  • Molecular Formula
    C6H3BrClNO2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    OC(=O)C1=NC(Cl)=CC=C1Br
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • (Met(O)27)-Glucagon ...

    (Met(O)27)-Glucagon (1-29) (human, rat, porcine) is a modified glucagon. (Met(O)27)-Glucagon (1-29) (human, rat, porcine) has the same maximum glucose-synthesizing activity in rat hepatocytes as native glucagon, but it is less potent, suggesting a crucial role of methionine in the binding of glucagon to its hepatic receptor.

  • Damulin A

    Damulin A is a natural product for research related to life sciences.

  • TrxR1-IN-B19

    TrxR1-IN-B19, a TrxR1 inhibitor, selectively kills gastric cancer cells by a small molecule via targeting TrxR1 and ROS-mediated ER stress activation.